Wed, 9 Jan 2008 03:28:08 +0000

CV Therapeutics Discloses Ranexa Sales (AP via Yahoo! Finance)

by Angina (Angina) @ Wed, 9 Jan 2008 03:28:08 +0000
Biopharmaceutical company CV Therapeutics Inc. expects fourth-quarter net revenue of about $21 million from sales of its chronic angina drug, Ranexa, according to a Securities and Exchange Commission filing Tuesday.
Healthy Living Centre